Baxter Recalls an IV Nutrition Solution After Stainless Steel Particles Turned Up Inside the Sterile Bag
Baxter International is recalling one lot of 70% Dextrose Injection due to stainless steel particles found in the solution. The affected lot, Y495066, was distributed to healthcare providers in select states, including Alabama, Georgia, and Tennessee. The company has not reported any adverse events. Patients using parenteral nutrition should contact their compounding pharmacy for guidance. This is the third IV product recall in recent weeks, according to the FDA.
How this was made
The 30-second read
Why it matters
The recall involves a single lot (Y495066) distributed in Alabama, Georgia, and Tennessee, with no reported adverse events. Impact on stock likely limited but could raise broader quality concerns.
Market read
A narrow, regional recall with minimal immediate financial impact but potential reputational risk for Baxter and the IV solutions sector.
What to watch
Potential supply shortages if additional lots are recalled; regulatory scrutiny could increase.
Background
Baxter International is a major supplier of sterile IV solutions; product recalls can affect reputation and short-term sales.
Ticker impact
Baxter International announced a recall of one lot of 70% Dextrose Injection due to stainless steel particles, the first report of this specific recall.
Potential modest downside of 1‑2% if investors weigh recall risk, limited to short term.
Recall is limited to a single lot and regional distribution; no adverse events reported, so market reaction likely muted.
Market effects
Highlights quality control risks in the sterile IV solutions sector, may prompt peers to review processes.
Southeast U.S. markets could see slight concern among healthcare providers handling home parenteral nutrition.
Limited global impact; recall is U.S.-focused with no immediate effect on worldwide supply chains.
Counterpoint
Recall is isolated and may be overblown; Baxter's broader product portfolio remains strong.
Key entities
- CompanyBaxter International
Manufacturer of the recalled IV nutrition solution.
- RegulatorFDA
Published the recall notice on the same day.
%252FBaxter%252520sign%252520on%252520the%252520building%252520in%252520Mississauga%25252C%252520Ontario_%252520Baxter%252520International%252520Inc_%252520By%252520JHVEPhoto.jpeg&w=3840&q=75)